Adding MTX to Pegloticase for 52 wks in gout
◦ Improved response rate by 30%
◦ Reduced discontinuation rate by 40%
◦ Greater resolution of tophi by 20%
◦ Similar safety profile in MTX vs non-MTX groups
Botson J MIRROR RCT https://t.co/ifXLdvOv0K #ACR22 #ACRBest @RheumNow
Links:
12-month Findings of the Randomized, Double-Blind, Placebo-Controlled, Multicen…
http://bit.ly/3g3M9Kb
12-11-2022
